DE:4YD Stock Latest News
Company AnnouncementsNanologica Calls EGM to Approve Rights Issue Guarantee Deal5d ago
Company AnnouncementsNanologica launches SEK 110.5m rights issue amid strategic shift and new CEO1w ago
Company AnnouncementsNanologica Revamps Strategy, Names New CEO and Plans SEK 110.5m Rights Issue1w ago
Company AnnouncementsNanologica Boosts Revenue on Syntagon Acquisition Amid CFO Transition2M ago
Company AnnouncementsNanologica Delays Q2 Report Amid Syntagon Integration2M ago
Company AnnouncementsNanologica Names Axel Elner as CFO Ahead of Commercial Expansion2M agoCompany AnnouncementsNanologica AGM Carries Forward Losses, Cuts Share Capital and Expands Issue Mandate5M ago
Company AnnouncementsNanologica Boosts Q1 Profit on Syntagon Deal and Strengthens Balance Sheet5M ago
Company AnnouncementsNanologica Boosts Share Capital After Completion of New Share Issues6M ago
Company AnnouncementsNanologica’s Syntagon Hires Vice President Business Development to Drive Growth6M ago
Company AnnouncementsNanologica Publishes Comprehensive Annual Report for 20256M ago
Company AnnouncementsNanologica Reshapes Leadership After Syntagon Acquisition to Drive Profitability6M agoCompany AnnouncementsNanologica Wins SEK 2 Million Production-Scale Order for Peptide Purification Media6M ago
Company AnnouncementsNanologica Expands Share Capital Through Directed Issues7M ago
Company AnnouncementsNanologica Reports Minor Neighboring Lab Incident With No Operational Damage7M ago
Company AnnouncementsNanologica Completes Fully Underwritten SEK 82.5 Million Rights Issue7M ago- Company AnnouncementsNanologica Board Set for Overhaul With New Industry Heavyweights7M ago
Company AnnouncementsNanologica Raises Capital Through Fully Subscribed Directed Share Issues7M agoCompany AnnouncementsNanologica Publishes Information Document for SEK 96 Million Share and Rights Issues8M ago
Company AnnouncementsNanologica Shareholders Approve Capital Expansion, Acquisition Financing and Rights Issue8M ago